相关实验视频

Updated: Jan 13, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K

在B细胞淋巴瘤中CAR-T细胞耗尽:当前状态,机制和潜在的解决方案

Ruocong Zhao1,2, Jianglong Xia1, Yuanyuan Zheng1

  • 1Department of Hematology and Oncology, Shenzhen University General Hospital, Shenzhen, China.

Molecular therapy. Oncology
|January 8, 2026
PubMed
概括

化学抗原受体T细胞 (CAR-T) 疗法对淋巴瘤有前途,但可能导致CAR-T细胞耗尽. 本综述探讨了耗尽机制和改善CAR-T治疗结果的策略.

关键词:
MT: 定期发行 定期发行细胞治疗疗法细胞治疗疗法仿制性抗原受体的仿制性抗原受体疲 疲 疲 疲 疲淋巴瘤淋巴瘤是什么

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.7K
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo05:14

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

757

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K